Quantcast

Latest Ingelheim am Rhein Stories

2014-10-14 04:22:12

BONN, Germany, October 14, 2014 /PRNewswire/ -- Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announces the first closing of its Series A financing round, raising EUR9.45 million. The round was co-led by Wellington Partners and Boehringer Ingelheim Venture Fund, and included NRW Bank and High-Tech Gruenderfonds (HTGF). Rigontec is developing synthetic ligands of a novel...

2014-09-15 23:06:32

The Nation’s Premier Annual Physical Activity and Hispanic Family Health Celebration Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Are Title Sponsor New York, NY (PRWEB) September 15, 2014 On Sunday, September 21, 2014, the Hispanic Federation will present its eighth annual family health and fitness fair ¡Vive tu vida! Get Up! Get Moving!® at Carnaval de la Cultura Latina. The event promotes Hispanic family physical activity and good nutrition for...

2014-09-02 23:06:21

The Nation’s Premier Annual Physical Activity and Hispanic Family Health Celebration Dallas, TX (PRWEB) September 02, 2014 On Saturday, September 6, 2014, The Concilio will present its eighth annual family health and fitness fair ¡Vive tu vida! Get Up! Get Moving!®. This event promotes Hispanic family physical activity and good nutrition for better health and wellness for people of all ages and all sizes. The event, which is free and open to the public, will be held at Kiest...

2014-08-17 23:00:12

All Aspects Of Litigation Surrounding The Federal Pradaxa Lawsuits Alleging Boehringer Ingelheim's Blood Thinner Caused Serious Internal Bleeding Have Been Suspended Until Completion Of A Settlement Agreement Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 18, 2014 The attorneys at Wright & Schulte LLC note all matters within the Pradaxa lawsuit litigation were recently placed on hold while plaintiffs’ attorneys and Pradaxa manufacturer Boehringer Ingelheim...

2014-08-13 23:11:30

Thousands of Pradaxa Lawsuits Currently Pending in U.S. Courts Accuse Boehringer Ingelheim of Failing to Provide Adequate Warnings Regarding Medication’s Alleged Bleeding Side Effects New York NY (PRWEB) August 13, 2014 Pradaxa Lawsuit News: As Pradaxa lawsuits continue to move forward in U.S. courts, several new reports published in the British Medical Journal are raising new questions about the data used to garner regulatory approval of the blood thinner. Among other things, the...

2014-06-19 23:17:50

Boehringer Ingelheim GmbH, a German pharmaceutical company, recently announced a settlement for approximately 4,000 claims related to injuries and deaths caused by the blood thinner Pradaxa. PHOENIX, AZ (PRWEB) June 19, 2014 The Arizona personal injury firm Phillips Law Group is investigating claims against Boehringer Ingelheim GmbH, the pharmaceutical company who makes the blood thinner Pradaxa. On May 28, a Bloomberg report announced that Boehringer had agreed to settle approximately...

2014-06-19 23:17:43

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle nearly 4,000 claims against the drug company for injuries and deaths caused by the blood thinner Pradaxa. MCALESTER, OK (PRWEB) June 19, 2014 The Edwards Law Firm, an Oklahoma pharmaceutical litigation firm, continues to investigate and pursue claims regarding Pradaxa, a blood thinner manufactured by Boehringer Ingelheim GmbH. A Bloomberg report on May 28 announced that Boehringer had agreed to pay $650 million...

2014-06-10 23:13:15

The Long Island, New York law firm of Rudolph F. X. Migliore, P. C. has announced the makers of the drug called Pradaxa have agreed to pay out 650 million to resolve most of the 4,000 cases filed in state and federal courts. (PRWEB) June 10, 2014 The New York Times states, “Pradaxa, which was approved in 2010, was the first in a new group of blood thinners intended to replace an older treatment, warfarin, which required patients to submit to frequent blood tests and adhere to a strict...

2014-06-05 23:01:35

A recent settlement announcement involving Pradaxa has been announced by the manufacture, Boehringer Ingelheim. Toledo, Ohio (PRWEB) June 05, 2014 Boehringer Ingelheim, the manufacturing company of the blood thinning drug Pradaxa, announced in May 2014 a $650 million settlement deal this week to settle approximately 4,000 state and federal lawsuits. Reported by TIME May 2014, Pradaxa was approved by the US Food and Drug Administration (FDA) in October 2010, Pradaxa is formulated for use...

2014-05-28 23:02:26

The Firm is evaluating Pradaxa bleeding claims on behalf of individuals who allegedly suffered life-threatening episodes of internal hemorrhaging due to their use of Pradaxa. New York, New York (PRWEB) May 28, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in federal court, Bernstein Liebhard LLP notes that the manufacturer of the blood thinner has acknowledged that a number of serious bleeding events were omitted from the original report on a clinical...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.